Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Axovant Sciences Ltd. | 465 000 | déclaré | 07 avr. 2017 | tx 1+465 000 |
| REGENERON PHARMACEUTICALS, INC. | 14 349 | déclaré | 09 déc. 2025 | tx 153+190 654−91 241 |
| CytomX Therapeutics, Inc. | 14 000 | déclaré | 20 juin 2017 | tx 2+42 000 |
| SCYNEXIS INC | 9 217 | déclaré | 02 juil. 2018 | tx 9+106 976 |
| MEDIVATION, INC. | 0 | déclaré | 28 sept. 2016 | tx 5+121 358−121 899 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 09 déc. 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 1 021 | 701.51 USD | |
| 05 déc. 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 2 476 | 0.00 USD | |
| 08 déc. 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 1 336 | 712.94 USD | |
| 05 déc. 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 12 210 | 0.00 USD | deriv |
| 16 déc. 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 759 | 730.81 USD | |
| 09 déc. 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 274 | 787.00 USD | |
| 06 déc. 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 2 332 | 0.00 USD | |
| 06 déc. 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 8 981 | 0.00 USD | deriv |
| 01 nov. 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 844.61 USD | |
| 01 nov. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 381.40 USD | |
| 01 nov. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 0.00 USD | deriv |
| 01 oct. 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 1054.06 USD | |
| 01 oct. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 381.40 USD | |
| 01 oct. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 0.00 USD | deriv |
| 03 sept. 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 1178.73 USD | |
| 03 sept. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 381.40 USD | |
| 03 sept. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 000 | 0.00 USD | deriv |
| 01 août 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 137 | 372.46 USD | |
| 01 août 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 137 | 1060.86 USD | |
| 01 août 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 137 | 0.00 USD | deriv |
| 01 juil. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 137 | 372.46 USD | |
| 01 juil. 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 137 | 1047.11 USD | |
| 01 juil. 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 137 | 0.00 USD | deriv |
| 03 juin 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 1 138 | 372.46 USD | |
| 03 juin 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1 138 | 980.16 USD |